Skip to main content

Table 5 Odds ratios variables independently associated with treatment choice identified by multivariate regression analysis

From: Management of osteoporosis and associated quality of life in post menopausal women

Variable Treatment modality
(Reference: Weekly BP)
Physician speciality Odds Ratio P
Age Monthly bisphosphonates   0.998 [0.982; 1.015] 0.8544
  Strontium ranelate   0.978 [0.957; 1.000] 0.0451
  SERM   0.909 [0.882; 0.938] < 0.0001
Paraclinical investigations Monthly bisphosphonates   2.158 [1.086; 4.288] 0.0281
  Strontium ranelate   1.451 [0.608; 3.463] 0.4017
  SERM   0.495 [0.213; 1.152] 0.1028
Osteoporotic fractures Monthly bisphosphonates   0.851 [0.632; 1.144] 0.2851
  Strontium ranelate   1.631 [1.104; 2.411] 0.0141
  SERM   0.501 [0.300; 0.837] 0.0083
Physician speciality Monthly bisphosphonates Rheumatologists 1.00 .
   Gynaecologists 0.908 [0.510; 1.618] 0.7431
   GPs 1.475 [1.051; 2.071] 0.0247
  Strontium ranelate Rheumatologists 1.00 .
   Gynaecologists 2.653 [1.486; 4.734] 0.0010
   GPs 0.605 [0.396; 0.924] 0.0020
  SERM Rheumatologists 1.00 .
   Gynaecologists 2.153 [1.081; 4.289] 0.0292
   GPs 0.857 [0.482; 1.524] 0.5998
Ongoing treatment at the time of consultation Monthly bisphosphonates   0.573 [0.426; 0.771] 0.0002
  Strontium ranelate   1.107 [0.751; 1.633] 0.6063
  SERM   0.928 [0.577; 1.492] 0.7576
  1. Odds ratios are presented with their 95% confidence intervals. The reference treatment group for calculation of odds ratios was women treated with weekly bisphosphonates (BP).